News
Successful results in subcutaneous repeated dose study in rats
TIRmed successfully completes key toxicity study
Leo Holmgren
March 5, 2024
TIRmed successfully completes key toxicity study
Leo Holmgren
March 5, 2024
In a recent development, TIRmed has conducted a biodistribution study that has yielded very promising results. The study, focused on dermal applications, marks a significant milestone in the company's ongoing research efforts.
February 26, 2024
TIRmed Pharma is pleased to announce the appointment of Pirkko Tamsen as a new member of its Board of Directors.
Ludde
March 5, 2024
We're excited to introduce our two new interns, Amirreza and Jianjian, who have been driving a market intelligence research project this spring.
Ludde
February 26, 2024
This post can address the challenges faced by family caregivers, offering guidance on managing caregiver stress.
Ludde
February 26, 2024
This post can provide guidance to families seeking memory care options for their loved ones.
Ludde
February 26, 2024
For more information or to schedule a tour, contact a sales consultant who can help you decide which community.
